An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone (RETURN)
This study has been completed.
Study NCT01142518
Information provided by Merck KGaA
First Received on June 10, 2010.
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
